CClinicalTrials.gg
WithdrawnNCT02994186Updated Sep 27, 2018

Examination of Cognitive Function in Obesity and Following Weight Loss

An observational study in Obesity, Bariatric Surgery Candidate and Weight Loss, sponsored by Vanderbilt University Medical Center. Withdrawn. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-09-27.

Sponsored by Vanderbilt University Medical Center · Observational

Why this study was withdrawn
funding
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Bariatric surgery is the most effective, long-term treatment for morbid obesity, and consistent with previous findings, individuals who lose significant weight after surgery also have improved cognition or "brain function". The mechanisms behind these cognitive improvements are currently unknown, but are the focus of much research effort. The goal of this pilot study is to thoroughly describe these changes in surgical versus medical weight loss patients over time in a repeated measures fashion.

Read the detailed description

Recent studies have demonstrated that obesity is associated with decreased cognitive function and, interestingly, weight loss is associated with improved cognitive function. Bariatric surgery is the most effective, long-term treatment for morbid obesity, and consistent with these previous findings, individuals who lose significant weight after surgery appear to have improved cognition. Previous results have only reported the appearance of cognitive improvements starting at three months postoperatively, thus, the main focus of this study is to discover whether cognitive function improvements are seen as early as one month after bariatric surgery. An acceleration in the onset of cognitive function changes could provide insight towards the ambiguous underlying neural mechanisms. The benefits of bariatric surgery extend beyond reversible cognitive deficits. Many of the medical comorbid conditions that these patients have before surgery (e.g. high blood pressure, high cholesterol, diabetes) typically resolve prior to any significant weight loss. The mechanisms for these weight-independent improvements are also undetermined. A secondary focus of this study is to determine whether or not cognitive function following bariatric surgery also improves prior to significant weight loss. To test whether cognitive function changes following bariatric surgery, two cohorts of surgical patients will be recruited as well as another group of patients undergoing medical weight loss treatment. The goal of this pilot study is to reproduce and expand upon previous findings that demonstrate cognitive improvements following bariatric surgery.

02

Conditions studied

  • Obesity
  • Bariatric Surgery Candidate
  • Weight Loss

Keywords

  • cognitive function
  • obesity
  • bariatric surgery
  • metabolic surgery
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

Browse Obesity studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients that will be recruited for this study are those individuals that are pursuing either medical or surgical weight loss options at the Vanderbilt Centers for Medical and Surgical Weight Loss.

Inclusion criteria

  • English speaking
  • Within the age rage of 18-70 years
  • Able to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Neurological disorder or previous injury (e.g. stoke, dementia, seizures, traumatic brain injury)
  • History of any moderate to severe head injury (i.e. >5 minutes of loss of consciousness)
  • History of severe psychiatric illness requiring current pharmacologic therapy(e.g. schizophrenia, bipolar disorder, personality disorders)
  • History of illicit drug or alcohol abuse
  • Known diagnosis of learning or developmental disability
  • Impaired sensory function
  • Any prior suicide attempt
  • Revisional bariatric surgery
  • Current or former tobacco user / smoker
  • Currently pregnant
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Surgical Weight Loss

    Patients in this group are those that will be undergoing bariatric surgery (either Roux-en-Y gastric bypass or vertical sleeve gastrectomy).

    Procedure: Bariatric Surgery

  • Medical Weight Loss

    Patients in this group are those who are being enrolled in a supervised medical weight loss program.

    Other: Medical Weight Loss Program

Interventions

  • ProcedureBariatric Surgery

    These are patients who will be having either Vertical Sleeve Gastrectomy or Roux-en-Y Gastric Bypass.

  • OtherMedical Weight Loss Program

    These are patients who will be starting a structured medical weight loss program.

06

What researchers measure

Primary outcomes

  1. Cognitive Function Score

    Within group and between group longitudinal measurements will be made using longitudinal regression methods. Baseline as well as 1, 3 and 6 month measurements will be captured either from the time of bariatric surgery or initiation of a supervised medical weight loss program.

    Time frame: Repeated Measures Up to 6 Months

  2. Cognitive Function Score - Surgical Group Comparison

    Within group and between group longitudinal measurements will be made using longitudinal regression methods. Baseline as well as 1, 3 and 6 month measurements will be captured either from the time of bariatric surgery or initiation of a supervised medical weight loss program. The bariatric operation will be included (Roux-en-Y gastric bypass vs. Vertical Sleeve Gastrectomy) as a variable in the regression model for between and within subjects comparisons in the bariatric surgery group.

    Time frame: Repeated Measures Up to 6 Months

Secondary outcomes

  1. Cognitive Function Score - Crossover Patients

    There will be a group of patients that will crossover at 6 months from the medical weight loss group to the surgical weight loss group. The cognitive function score in these patients will be compared between treatment groups, as they will effectively be represented in each group.

    Time frame: Repeated Measures Up to 6 Months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02994186
Lead sponsor
Vanderbilt University Medical Center
Collaborators
Lumos Labs, Inc.
Responsible party
Vance L. Albaugh, MD, PhD (Postdoctoral Fellow and Resident Surgeon, Vanderbilt University Medical Center) — Principal investigator
First posted
Dec 15, 2016
Start date
Jul 1, 2018 (estimated)
Primary completion
Dec 2019 (estimated)
Completion
Jul 2020 (estimated)
Last update
Sep 27, 2018

Study contacts

Vance L Albaugh, MD, PhD
principal investigator · Vanderbilt University Medical Center
Naji N Abumrad, MD
study director · Vanderbilt University Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion